ARGOS THERAPEUTICS INC - COM (ARGS)

Historical Holders from Q1 2014 to Q3 2018

Symbol
ARGS
Type / Class
Equity / COM
All holders as of 30 Sep 2018
Q3 2018
Total 13F shares, excl. options
826,153
Holdings value
$83,000
Number of holders
1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ARGOS THERAPEUTICS INC - COM (ARGS)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2018 Q3 826,153 $83,000 $0.101 1
2018 Q2 826,153 $136,000 $0.1643 1
2018 Q1 826,153 $744,000 -$392,150 $0.8994 1
2017 Q4 2,616,419 $392,150 -$47,997 $0.1501 18
2017 Q3 16,101,341 $2,888,001 +$61,216 $0.1788 22
2017 Q2 15,333,908 $5,565,000 -$533,874 $0.3604 31
2017 Q1 16,705,488 $7,544,008 -$4,201,712 $0.4499 35
2016 Q4 20,809,814 $101,969,985 +$6,420,332 $4.9 49
2016 Q3 6,335,412 $31,479,128 +$8,780,369 $4.97 46
2016 Q2 4,549,925 $27,806,219 +$6,296,678 $6.13 43
2016 Q1 1,118,675 $7,157,000 -$1,135,008 $6.4 20
2015 Q4 4,026,732 $9,301,000 -$3,226,124 $2.31 23
2015 Q3 4,519,327 $21,962,000 -$879,212 $4.83 24
2015 Q2 4,633,724 $31,806,000 -$812,630 $6.85 19
2015 Q1 4,603,134 $41,010,564 +$5,968,162 $8.91 24
2014 Q4 3,926,309 $39,107,660 +$712,040 $10 26
2014 Q3 3,855,156 $38,782,684 -$4,153,532 $10.06 25
2014 Q2 4,338,015 $34,717,043 -$2,541,126 $8.03 30
2014 Q1 4,586,742 $45,781,000 +$45,781,000 $10 32